HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 242 filers reported holding HORIZON PHARMA PLC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,898,000 | +206.7% | 109,700 | +126.6% | 0.17% | +171.9% |
Q4 2018 | $945,000 | +0.5% | 48,406 | +0.8% | 0.06% | +60.0% |
Q3 2018 | $940,000 | +18.2% | 48,000 | 0.0% | 0.04% | +8.1% |
Q2 2018 | $795,000 | +47.2% | 48,000 | +26.3% | 0.04% | +37.0% |
Q1 2018 | $540,000 | -49.8% | 38,000 | -48.4% | 0.03% | -48.1% |
Q4 2017 | $1,076,000 | +15.2% | 73,687 | 0.0% | 0.05% | +13.0% |
Q3 2017 | $934,000 | +67.4% | 73,687 | +56.5% | 0.05% | +70.4% |
Q2 2017 | $558,000 | -9.0% | 47,087 | +13.5% | 0.03% | -27.0% |
Q1 2017 | $613,000 | -56.4% | 41,487 | -52.3% | 0.04% | -51.9% |
Q4 2016 | $1,407,000 | +3.5% | 86,960 | +16.0% | 0.08% | +16.7% |
Q3 2016 | $1,360,000 | +144.6% | 74,960 | +121.8% | 0.07% | +78.4% |
Q2 2016 | $556,000 | +8.2% | 33,800 | +9.0% | 0.04% | +15.6% |
Q1 2016 | $514,000 | -74.4% | 31,000 | -66.5% | 0.03% | -73.1% |
Q4 2015 | $2,007,000 | +913.6% | 92,560 | +825.6% | 0.12% | +891.7% |
Q3 2015 | $198,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |